Biologics
Check out the latest Biologics news being talked about today across the world.
-
Xtant Medical Highlights Growing Product Portfolio at NASS 2023
BELGRADE, Mont., Oct. 12, 2023…
Read More » -
Tetrous, Inc. Announces Issue of an Additional U.S. Patent Related to EnFix™ Demineralized Bone Fiber Implants for Sports Medicine Surgical Procedures
LOS ANGELES, Oct. 5, 2023 /PRNewswire/ —…
Read More » -
U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA
ATLANTA, Oct. 4, 2023 /PRNewswire/ — The…
Read More » -
Theradaptive Awarded DOD Clinical Trial Award of up to $7.4 Million
FREDERICK, Md., Sept. 26, 2023 /PRNewswire/ —…
Read More » -
Study Published in Nature Reveals Discovery of Unique Vertebral Stem Cells with Potential to Revolutionize Patient Care
Hospital for Special Surgery and…
Read More » -
2,000 patients treated with OssDsign® Catalyst in the U.S.
Uppsala, September 13, 2023. OssDsign…
Read More » -
Spine Biologics Market to hit USD 3.4 billion by 2032, says Global Market Insights Inc.
Spine Biologics Industry is projected…
Read More »